| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2590 | |||||||||||||||||||||||
| Submitter : | Mrs. Michaela Berquist | Date & Time: | 12/05/2006 10:12:57 | |||||||||||||||||||||
| Organization : | Mrs. Michaela Berquist | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Reference Public Comments: Docket Number 2006D-0383
Please do not use Aborted Fetal Cell lines in developing vaccines. Please use the ethical cell lines in developing vaccines so that all people can benefit from them without compromising their moral beliefs and pro-life convictions. | ||||||||||||||||||||||||